Reddoch James F.
- SEC CIK
- 0001814872
No open-market purchases or sales filed in the past year.
Current role at each company
- RPRX Royalty Pharma plcEVP & Chief Scientific Officeras of Sep 30, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Reddoch James F. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2022 (view filing) | Sep 28 | 2 days | Reddoch James F.EVP & Chief Scientific Officer | SSaleClass A Ordinary Shares | −100.0K | $41.23 | −$4.12M | −10.9%820.8K after | |
| Jun 10, 2022 (view filing) | Jun 8 | 2 days | Reddoch James F.EVP & Chief Scientific Officer | SSaleClass A Ordinary Shares | −100.0K | $41.56 | −$4.16M | −9.8%920.8K after | |
| May 31, 2022 (view filing) | May 27 | 4 days | Reddoch James F.EVP & Chief Scientific Officer | SSaleClass A Ordinary Shares | −75.0K | $41.08 | −$3.08M | −6.8%1.02M after | |
| May 23, 2022 (view filing) | May 19 | 4 days | Reddoch James F.EVP & Chief Scientific Officer | SSaleClass A Ordinary Shares | −75.0K | $40.44 | −$3.03M | −6.4%1.10M after | |
| Jul 27, 2021 (view filing) | Jul 26 | 1 day | Reddoch James F.EVP, Research & Investments | SSaleClass A Ordinary Shares | −8.95K | $39.78 | −$356.0K | −0.8%1.17M after | Duplicate filing |
| Jul 27, 2021 (view filing) | Jul 26 | 1 day | Reddoch James F.EVP, Research & Investments | SSaleClass A Ordinary Shares | −8.95K | $39.78 | −$356.0K | −0.8%1.17M after | |
| Jul 14, 2021 (view filing) | Jul 12-14 | 2 days | Reddoch James F.EVP, Research & Investments | SSaleClass A Ordinary Shares | −17.9K | $42.01 | −$753.4K | −1.5%1.18M after | 3 lots |
| Jul 8, 2021 (view filing) | Jul 6-8 | 2 days | Reddoch James F.EVP, Research & Investments | SSaleClass A Ordinary Shares | −73.1K | $42.19 | −$3.09M | −5.8%1.20M after | 3 lots |